Pershing Square Inc. (PS) has dropped 25 percent from its Oct. 7 peak of $60 per share, trading at $45 following back-to-back downgrades from Citi and Bank of America.
Citi downgraded Pershing Square to Sell from Neutral, maintaining a $45 price target but slashing its 2027 earnings per share estimate to $0.89 from $1.01. The firm cites a forward valuation of 54 times earnings—elevated for an asset manager facing headwinds. Citi's core critique: tepid investment performance across Pershing Square Holdings and Pershing Square USA will pressure management fees, which are sensitive to assets under management.
BofA followed suit this week, moving the stock to Underperform from Neutral and cutting its price target from $54 to $38, implying a 15 percent downside over the next 12 months. Both firms point to the same core problem: a premium valuation paired with near-term return expectations that do not justify the multiple.
Ackman took Pershing Square public on April 29 at $24 per share, capturing a 150 percent gain to the October peak. The IPO capitalized on investor appetite for Ackman's activist playbook and his conviction in Pershing Square Holdings and affiliate funds. That enthusiasm has cooled as equity markets absorbed the reality of modest fund performance and the firm's dependency on assets under management for fee revenue.
Citi flagged one potential upside catalyst: Pershing Square's controlling stake in Howard Hughes Holdings. The real estate developer recently acquired specialty insurer Vantage Group Holdings—a move Ackman characterized in his Q2 shareholder letter as positioning the firm to operate like a modern Berkshire Hathaway, using insurance float to deploy capital opportunistically. If that float model generates outsized returns, it could lift Pershing Square's intrinsic value. For now, the market is discounting that thesis.
Ackman also plans to launch Pershing Square Ventures by end-of-2026, a private equity fund offering pre-IPO access. The new vehicle could diversify revenue and open a higher-margin business line—but it remains early-stage and dependent on deployment execution.
The gap between the two downgrades' price targets ($45 at Citi, $38 at BofA) reflects genuine uncertainty about where Pershing Square settles. At $45, investors are essentially pricing in a reversal of the fund's recent underperformance and material near-term capital deployment from Howard Hughes. At $38, they are pricing in more of the same—modest returns, stable fees, and no meaningful catalysts. The stock's next move will hinge on Q3 fund performance and visibility into Howard Hughes' acquisition integration.
